LIFE - aTyr Pharma, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/17/2023
Current
3/31/202312/31/20229/30/20226/30/20223/31/2022
Market Cap (intraday)
135.56M111.64M63.53M87.03M79.60M150.10M
Enterprise Value
80.95M57.03M-5.19M-251.85k-17.92M43.57M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
7.035.75N/AN/AN/AN/A
Price/Book (mrq)
1.911.560.821.000.811.37
Enterprise Value/Revenue
7.79N/A-0.50N/AN/AN/A
Enterprise Value/EBITDA
-1.81-4.740.650.021.46-3.61

Trading Information

Stock Price History

Beta (5Y Monthly) 1.22
52-Week Change 3-18.28%
S&P500 52-Week Change 32.54%
52 Week High 34.2800
52 Week Low 31.5550
50-Day Moving Average 32.1193
200-Day Moving Average 32.4440

Share Statistics

Avg Vol (3 month) 3646.31k
Avg Vol (10 day) 3623.75k
Shares Outstanding 554.29M
Implied Shares Outstanding 6N/A
Float 843.88M
% Held by Insiders 110.03%
% Held by Institutions 158.98%
Shares Short (May 14, 2023) 4410.64k
Short Ratio (May 14, 2023) 40.37
Short % of Float (May 14, 2023) 41.16%
Short % of Shares Outstanding (May 14, 2023) 40.76%
Shares Short (prior month Apr 13, 2023) 4399.49k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jun 30, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:14
Last Split Date 3Jun 30, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-450.73%

Management Effectiveness

Return on Assets (ttm)-24.22%
Return on Equity (ttm)-43.39%

Income Statement

Revenue (ttm)10.39M
Revenue Per Share (ttm)0.32
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-32.42M
EBITDA -46.58M
Net Income Avi to Common (ttm)-45.14M
Diluted EPS (ttm)-1.3400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)114.39M
Total Cash Per Share (mrq)2.11
Total Debt (mrq)14.29M
Total Debt/Equity (mrq)13.02
Current Ratio (mrq)8.75
Book Value Per Share (mrq)2.06

Cash Flow Statement

Operating Cash Flow (ttm)-32.36M
Levered Free Cash Flow (ttm)-20.61M